Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 26,013 |
|
|||||
| News | - | ||||||
| Day High | 9.94 | Low High |
|||||
| Day Low | 9.00 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Serina Therapeutics Inc | SER | AMEX | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.15 | -1.58% | 9.35 | 15:19:48 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 9.52 | 9.00 | 9.94 | 9.41 | 9.50 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 585 | 26,013 | US$ 9.28 | US$ 241,408 | - | 7.86 - 19.93 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 19:00:00 | 1,657 | US$ 9.41 | USD |
Serina Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 342.7M | 37.95M | - | 142k | -14.8M | -0.39 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Serina Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/23/2024 | 16:07 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 5/14/2024 | 15:25 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/14/2024 | 15:16 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 5/14/2024 | 15:05 | GlobeNewswire Inc. | Serina Therapeutics Reports First Quarter 2024 Financial.. |
| 4/17/2024 | 15:05 | GlobeNewswire Inc. | Serina Therapeutics Appoints Dr. Simba Gill as Executive.. |
| 3/26/2024 | 16:04 | GlobeNewswire Inc. | Serina Therapeutics Announces Completion of Merger with AgeX.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SER Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 9.52 | 10.70 | 9.00 | 9.70 | 16,085 | -0.17 | -1.79% |
| 1 Month | 8.50 | 12.9782 | 7.86 | 9.35 | 17,356 | 0.85 | 10.00% |
| 3 Months | 11.68 | 19.93 | 7.86 | 10.33 | 10,032 | -2.33 | -19.95% |
| 6 Months | 11.68 | 19.93 | 7.86 | 10.33 | 10,032 | -2.33 | -19.95% |
| 1 Year | 11.68 | 19.93 | 7.86 | 10.33 | 10,032 | -2.33 | -19.95% |
| 3 Years | 11.68 | 19.93 | 7.86 | 10.33 | 10,032 | -2.33 | -19.95% |
| 5 Years | 11.68 | 19.93 | 7.86 | 10.33 | 10,032 | -2.33 | -19.95% |
Serina Therapeutics Description
| AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547. |
